Preoperative sterile pyuria as a prognostic biomarker for intravesical recurrence in upper urinary tract urothelial carcinoma

Investig Clin Urol. 2020 Jan;61(1):51-58. doi: 10.4111/icu.2020.61.1.51. Epub 2019 Dec 19.

Abstract

Purpose: To evaluate if preoperative sterile pyuria can be a prognostic factor for intravesical recurrence (IVR) and overall survival (OS)in patients with upper tract urothelial carcinoma (UTUC) undergoing surgery.

Materials and methods: We retrospectively reviewed the medical records of patients who were diagnosed with UTUC from October 2003 to December 2016 at Korea University Medical Center. Sterile pyuria was defined as urine containing five or more white blood cells per high-power field in the absence of bacteria in urine culture. We used a stepwise multivariable Cox proportional hazards model to assess the independent effects of the prognostic factors for IVR and OS.

Results: We investigated a total of 176 patients who were diagnosed with UTUC. Among them, 91 (51.7%) patients had preoperative sterile pyuria. There were no significant differences in the baseline characteristics between the pyuria and non-pyuria groups concerning tumor grade, T stage, tumor multiplicity, and recurrence history. However, there was a significant difference in the IVR between the two groups. In the multivariable analysis, preoperative sterile pyuria, diabetes mellitus, high-grade tumor, and lymphovascular invasion were revealed as independent risk factors for IVR, and only lymphovascular invasion was identified as an independent risk factor for OS.

Conclusions: Preoperative sterile pyuria is significantly associated with IVR in patients with UTUC undergoing surgery, but it is not associated with OS. Furthermore, diabetes mellitus, high-grade tumor, and lymphovascular invasion are also independent prognostic factors for these patients.

Keywords: Prognosis; Pyuria; Recurrence; Urinary bladder; Urologic neoplasms.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Carcinoma, Transitional Cell* / pathology
  • Carcinoma, Transitional Cell* / surgery
  • Carcinoma, Transitional Cell* / urine
  • Female
  • Humans
  • Leukocyte Count* / methods
  • Leukocyte Count* / statistics & numerical data
  • Male
  • Middle Aged
  • Neoplasm Grading
  • Neoplasm Recurrence, Local* / diagnosis
  • Neoplasm Recurrence, Local* / etiology
  • Neoplasm Staging
  • Outcome Assessment, Health Care
  • Perioperative Period
  • Predictive Value of Tests
  • Prognosis
  • Pyuria* / diagnosis
  • Pyuria* / urine
  • Risk Assessment / methods
  • Urologic Neoplasms* / pathology
  • Urologic Neoplasms* / surgery
  • Urologic Neoplasms* / urine
  • Urologic Surgical Procedures / adverse effects*
  • Urologic Surgical Procedures / methods